Physician profile
Daniel P Loder
NPI 1760472500
$5,171.51
in general payments reported to CMS, 2019-2025
19 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,559 · 2020: $306 · 2021: $893 · 2022: $709 · 2023: $1,027 · 2024: $532 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,603 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,603.20 |
| Education | $101.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,814.40 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $488.81 | 2020-2024 | Senza |
| Abbott Laboratories | $398.50 | 2021-2024 | Proclaim, Eterna |
| Nalu Medical, INC. | $369.55 | 2021-2023 | Nalu Neurostimulation System |
| Stryker Corporation | $192.91 | 2021 | |
| Medtronic, INC. | $160.18 | 2021 | |
| Vertos Medical, INC. | $142.08 | 2022 | |
| Curonix LLC | $120.87 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Relievant Medsystems, INC. | $115.15 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $76.29 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $67.00 | 2020 | |
| Spr Therapeutics, INC | $48.97 | 2023 | Sprint Pns System |
| Stimwave Technologies Incorporated | $42.98 | 2021 | |
| Smith+Nephew, INC. | $30.11 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Globus Medical, INC. | $27.24 | 2025 | Senza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $23.21 | 2021 | |
| Lilly USA, LLC | $20.74 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.47 | 2021 | |
| Horizon Therapeutics Plc | $14.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Loder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.